Publications by authors named "M Hiligsmann"

Claim this Profile
E
Economics perspectives on understanding antimicrobial use and resistance: a scoping review from theory to practice.
Katia Iskandar, Christine Roques, Pascale Salameh, Rana Rizk, Jalal Dahham, Mickaël Hiligsmann

Expert Rev Pharmacoecon Outcomes Res· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Infectious diseases, infection control, vaccines and long-term care: an European interdisciplinary Council on ageing consensus document.
Nicola Veronese, Jane Barratt, Eveline Coemans, Pete Dayananda, Marco Del Riccio, Mickael Hiligsmann

Aging Clin Exp Res· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Model-Based Economic Evaluation of the First-in-Class Myosin Inhibitor Mavacamten Versus Care as Usual in Obstructive Hypertrophic Cardiomyopathy Patients from a Dutch Societal Perspective.
Isabell Wiethoff, Willem J A Witlox, Silvia M A A Evers, Michelle Michels, Mickaël Hiligsmann

Pharmacoeconomics· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patients' preferences for atopic dermatitis treatments in Europe: a discrete choice experiment.
Katja C Heinz, Charlotte Beaudart, Axel De Greef, Olivier Vanhooteghem, Antoni Gostynski, Mickaël Hiligsmann

Expert Rev Pharmacoecon Outcomes Res· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of outcomes, costs, and feasibility of home-based geriatric rehabilitation after inpatient rehabilitation: study protocol of the "Better@Home" multicentre prospective cohort study with historical control group.
M C Pol, E F van Dam van Isselt, A J Doornebosch, C J Gamble, M Vaz, M Hiligsmann

BMC Geriatr· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis